Adrenocortical Carcinoma
Symptoms, Doctors, Treatments, Advances & More

Learn About Adrenocortical Carcinoma

What is the definition of Adrenocortical Carcinoma?

Adrenocortical carcinoma (ACC) is a cancer of the adrenal glands. The adrenal glands are two triangle-shaped glands. One gland is located on top of each kidney.

What are the alternative names for Adrenocortical Carcinoma?

Tumor - adrenal; ACC - adrenal

What are the causes of Adrenocortical Carcinoma?

ACC is most common in children younger than 5 years old and adults in their 40s and 50s.

The condition may be linked to a cancer syndrome that is passed down through families (inherited). Both men and women can develop this tumor.

ACC can produce the hormones cortisol, aldosterone, estrogen, or testosterone, as well as other hormones. In women the tumor often releases these hormones, which can lead to male characteristics.

ACC is very rare. The cause is unknown.

What are the symptoms of Adrenocortical Carcinoma?

Symptoms of increased cortisol or other adrenal gland hormones may include:

  • Fatty, rounded hump high on the back just below the neck (buffalo hump)
  • Flushed, rounded face with pudgy cheeks (moon face)
  • Obesity
  • Stunted growth (short stature)
  • Virilization -- the appearance of male characteristics, including increased body hair (especially on the face), pubic hair, acne, deepening of the voice, and enlarged clitoris (females)

Symptoms of increased aldosterone are the same as symptoms of low potassium, and include:

  • Muscle cramps
  • Weakness
  • Pain in the abdomen
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Adrenocortical Carcinoma?

The primary treatment is surgery to remove the tumor. ACC may not improve with chemotherapy. Medicines may be given to reduce production of cortisol, which causes many of the symptoms.

Who are the top Adrenocortical Carcinoma Local Doctors?
Elite in Adrenocortical Carcinoma
Endocrinology
Elite in Adrenocortical Carcinoma
Endocrinology

University Of Colorado Hospital Authority

1635 Aurora Ct, 
Aurora, CO 
Languages Spoken:
English
Offers Telehealth

Margaret Wierman is an Endocrinologist in Aurora, Colorado. Dr. Wierman is rated as an Elite provider by MediFind in the treatment of Adrenocortical Carcinoma. Her top areas of expertise are Adrenocortical Carcinoma, Pituitary Tumor, Adrenal Cancer, Hypothalamic Tumor, and Hormone Replacement Therapy (HRT).

Elite in Adrenocortical Carcinoma
Endocrinology
Elite in Adrenocortical Carcinoma
Endocrinology

UT MD Anderson Cancer Center

1515 Holcombe Blvd, 
Houston, TX 
Languages Spoken:
English

Mouhammed Habra is an Endocrinologist in Houston, Texas. Dr. Habra is rated as an Elite provider by MediFind in the treatment of Adrenocortical Carcinoma. His top areas of expertise are Adrenocortical Carcinoma, Adrenal Cancer, Thyroid Cancer, Tissue Biopsy, and Thyroidectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Adrenocortical Carcinoma
Endocrinology
Elite in Adrenocortical Carcinoma
Endocrinology

University Of Michigan Medical Center

1500 E Medical Center Dr, 
Ann Arbor, MI 
Languages Spoken:
English

Gary Hammer is an Endocrinologist in Ann Arbor, Michigan. Dr. Hammer is rated as an Elite provider by MediFind in the treatment of Adrenocortical Carcinoma. His top areas of expertise are Adrenal Cancer, Adrenocortical Carcinoma, Neuroblastoma, and Hereditary Neuroblastoma.

What is the outlook (prognosis) for Adrenocortical Carcinoma?

The outcome depends on how early the diagnosis is made and whether the tumor has spread (metastasized). Tumors that have spread usually lead to death within 1 to 3 years.

What are the possible complications of Adrenocortical Carcinoma?

The tumor can spread to the liver, bone, lung, or other areas.

When should I contact a medical professional for Adrenocortical Carcinoma?

Contact your provider if you or your child has symptoms of ACC, Cushing syndrome, or failure to grow.

What are the latest Adrenocortical Carcinoma Clinical Trials?
A Phase II Study of Cabozantinib in Combination With Cemiplimab (Cabo-Cemiplimab) Versus Cabozantinib Alone in Adolescents and Adults With Advanced Adrenocortical Cancer

Summary: This phase II trial compares the effect of giving cabozantinib with or without cemiplimab in patients with adrenocortical cancer that has spread to nearby tissue or lymph nodes (locally advanced), and that cannot be removed by surgery (unresectable) or that has come back after a period of improvement (recurrent) or that has spread from where it first started (primary site) to other places in the b...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: August 21, 2024
Published By: Warren Brenner, MD, Oncologist, Lynn Cancer Institute, Boca Raton, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Habra M, Else T, Fassnacht M. Adrenocortical carcinoma. In: Robertson RP, ed. DeGroot's Endocrinology. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 98.

National Cancer Institute website. Adrenocortical carcinoma treatment (PDQ) - health professional version. www.cancer.gov/types/adrenocortical/hp/adrenocortical-treatment-pdq. Updated August 25, 2022. Accessed August 27, 2024.

Yeh MW, Livhits M, Duh Q-Y. The adrenal glands. In: Townsend CM Jr, Beauchamp RD, Evers BM, Mattox KL, et al, eds. Sabiston Textbook of Surgery. 21st ed. St Louis, MO: Elsevier; 2022:chap 40.